ArticleAnnals of translational medicine2023

Considerations for adjuvant immunotherapy in stage II melanoma: KEYNOTE-716 and beyond.

Lanyi Nora Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.